-
Listing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemLes merSeamless listing, trading, clearing and settlement for fixed income
-
Trading
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemLes mer
Seamless listing, trading, clearing and settlement for fixed income
-
Clearing
Connecting Europe's Fixed Income MarketsOne connected fixed income ecosystemLes mer
Seamless listing, trading, clearing and settlement for fixed income
-
CSD
European CSD modelBuilding the CSD of Choice in EuropeLes merEuronext Securities is shaping the future of European capital markets by enhancing integration, connectivity, and innovation.
-
Technology
Euronext Technology SolutionsHigh-Frequency Trading Solution (HFTS)Les merThe new generation of high-frequency risk trading platforms, offering the highest performance with ultra-low latency and minimal jitter, all at a low total cost of ownership.
-
Data
-
Indices
Access the white paperNext generation of indicesLes merThis white paper marks the second edition of Euronext’s Index Outlook series, a recurring publication designed to give investors deeper insight into our index innovation agenda and the structural forces shaping global markets.
-
About Euronext
Euronext strategic planInnovate for Growth 2027Les merShaping capital markets for future generations
Initial public offering of Genticel on Euronext Paris
04/04/2014
Benedikt Timmerman, CEO & Founder of Genticel, opens the trading day in Paris.
Genticel is a French pharmaceutical company, specialising in the development of therapeutic vaccines aimed at eliminating, at an early stage, the Human Papilloma Virus (HPV) responsible for cervical cancer.